This compound serves as a protected intermediate in pharmaceutical synthesis, particularly for producing kinase inhibitors in targeted cancer therapies. It incorporates a 1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-yl core, where the THP group protects the indazole nitrogen to improve handling and selectivity. The side chain features a Boc-protected amine (tert-butoxycarbonyl group), which enhances synthetic stability and can be deprotected post-reaction. This structure facilitates selective enzyme binding and modulation of cellular signaling pathways, making it essential in research for enhancing drug potency, solubility, and metabolic stability.